IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions and radiation therapy integrated quality assurance (QA) for the treatment of cancer, announces the acceptance and beam model validation of the first Varian Halcyon machine in Europe to go clinical, at the hospital UZ Leuven in Belgium, using IBA Dosimetry’s Blue Phantom water phantom system.
A team under the direction of chemist Prof. Dr Peter Comba is investigating radioactive metal complexes for use in the diagnosis and treatment of tumors.
Patients with unresectable, or inoperable, lung cancer are often given a dismal prognosis, with low rates of survival beyond a few years. Researchers exploring combination therapies have recently discovered improved survival rates by up to one year when patients treated with a newly formulated chemotherapy regimen are also given radiation therapy.
Unlike the USA, Italy, Germany or the Netherlands, Spain does not include hyperthermia in its national health catalogue. Worse, many non-medical centres are increasingly offering hyperthermia as an alternative treatment, a situation that infuriates Spanish oncologic radiotherapists.
The UC Davis Comparative Oncology Program joins oncologists at both the vet school and cancer center to test novel treatments on companion dogs with spontaneous tumors that could be effective in human patients with cancer. Human clinical trials could be started this year.
IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions and radiation therapy integrated quality assurance (QA) for the treatment of cancer, announces the release of myQA version 2017-001. This new version further enhances the integration of quality assurance across all QA applications, departments and people.
Patients with early stage pancreatic cancer could be given longer to live if they receive radiotherapy at a high enough dose, according to research presented at the ESTRO 36 conference.
Doctors have found that treating prostate cancer with a single, high dose of radiation delivered precisely to the site of the tumour results in good quality of life and fewer trips to the hospital, with adverse side effects that are no worse than if the radiation treatment had been given in several lower doses.
Although radiation therapy is an essential part of modern cancer treatment, and is indicated for about half of all new cancer patients, facilities for its provision are sadly lacking in many countries worldwide. Indeed, 29 out of 52 African nations have no radiotherapy facilities whatsoever. At the ESTRO 36 conference leaders of the European Society for Radiotherapy and Oncology (ESTRO) will…
Innovative Dolphin® system clinically implemented at the Gaziosmanpasa Hospital, Istanbul, ensuring high quality and efficient radiosurgery and SBRT treatment QA
Patients with locally advanced rectal cancer have been treated with intra-operative radiotherapy (IORT) for over twenty years. Partly due to this type of radiation, survival rates in a group of patients considered to have inoperable cancer changed dramatically from five to 70 percent.
Accuray Incorporated announced today that the first centers in Qatar, Latvia, and Bulgaria are now equipped with its radiation therapy technology, demonstrating continued momentum in adoption of its devices in Europe, India, the Middle East and Africa (EIMEA). The CyberKnife® and TomoTherapy® Systems are now used in more than 40 countries to treat patients across the full spectrum of radiation…
Before 2013, when Professor Dietmar Dinter became partner of Radiologie Schwetzingen, a multi-discipline group practice specialised in radiology and nuclear medicine, he was senior resident at the Institute of Clinical Radiology and Nuclear Medicine at University Hospital Mannheim (2003-2012) and head of its Nuclear Medicine Department (2009-2012). Was his work in nuclear medicine altered by the…
Radiotherapy is being proposed to treat heart diseases, specifically for hypertension and atrial fibrillation (AF).
IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces that it has signed final contracts concluding the Essen project negotiation with the University Hospital of Essen (UK Essen).
Partnerships are at the top of the agenda for RSNA 2013. To meet current and emerging challenges, “we need internal partnerships within radiology and external ones with our clinical peers as well as with our patients,” outlined Sarah S. Donaldson, MD in her opening address of the 99th RSNA Scientific Assembly and Annual Meeting.
]‘We are very pleased to be able to offer our patients top quality and, most importantly, very precise radiotherapy,’ said Professor Wolfgang Mohnike, Medical Director of the Diagnostic and Therapeutic Centre (DTZ) in Berlin – one of the leading outpatient cancer centres in the city. The newly equipped Radiotherapy Centre at the DTZ was inaugurated at the beginning of June and the new…
Currently there is a truly enormous hole in the ground in the city of Wiener Neustadt, Austria, but by summer 2012 MedAustron, one of the most modern centres for ion therapy and research in Europe, is to be built here.
PBT uses a high-energy beam of particles to destroy cancer cells by more accurately targeting the affected areas and is particularly suitable for complex childhood cancers. It also increases success rates and reduces side effects, such as deafness, loss of IQ and secondary cancers.
Every year in Germany, four million wounds leave a legacy of 30 000 amputations and six billion Euros in treatment costs. These shocking figures drew wound experts to the Pflege Kongress 2012 (2012 Care Congress) held in Berlin.
Following the acquisition of an Elekta Axesse system, which provides 3-D image guidance technology for conventional and stereotactic radiation therapy techniques, Helsinki University Central Hospital (HUCH) in Finland reports that, after eight months its image guided radiation therapy (IGRT) of lung, brain, pelvis, head and neck tumours has increased by up to 30 patients daily.
A combination of several well-known safety procedures could greatly reduce patient-harming errors in the use of radiation to treat cancer, according to a new study led by Johns Hopkins researchers.
Yes, it’s in beautiful Dresden again and -- as in 2006 when the city last hosted the Congress of the German Society for Senology -- this year’s Congress President is Professor Rüdiger Schulz-Wendtland (Department of Radiology, University of Erlangen). However, the repetition ends there; the congress topics will be anything but repeated. Report: Meike Lerner
A major public hospital has become the first in Paris to be equipped with a Gamma Knife, the device that enables the surgeon to operate on the brain with no blade or blood involved.
IBA Group, a leader in advanced cancer diagnosis and therapy technologies and Royal Philips Electronics, announced they have entered into an agreement to create state of the art patient-centric proton therapy centers.